Nivagen Pharmaceuticals, Inc.
Vishal Narang, currently working as the Senior General Manager of Clinical Drug Development at Nivagen Pharmaceuticals, has an extensive background in the pharmaceutical industry. With experience in roles such as Director of Clinical Project Leadership and Operations at Cipla, Director at Quintiles, and Visiting Faculty at Ramniranjan Jhunjhunwala College, Vishal's expertise lies in strategic planning, operational execution of clinical programs, and developing clinical-staff specific courses. Throughout their career, Vishal has demonstrated a strong commitment to excellence in clinical trial management and has a solid educational foundation, holding a Ph.D. in Pharmaceutical Sciences and an MBA in Business Development.
This person is not in any offices
Nivagen Pharmaceuticals, Inc.
Nivagen is engaged in the development, acquisition, and sales of generic prescription drugs and over the counter products for the North American market. It envisions to deliver high-quality products at affordable prices by leveraging global partnerships with the best FDA approved manufacturing facilities across the world.The US genericprescription market is currently at approximately $60 billion, and over $120 billion's worth of products will be coming off of patent protection in the next 10 years. Nivagen believes that, with its strategic partnership model of global alliances with highly efficient pharmaceutical companies across the globe, they can provide cost savings to the consumer while creating value for all members of the supply chain.